Related Experiment Video
Updated: May 30, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
FOXR2 in cancer development: emerging player and therapeutic opportunities
Piao Yang1, Mohsen Sheykhhasan2, Reza Heidari3
1Department of Molecular Genetics, College of Arts and Sciences, The Ohio State University, Columbus, OH, USA.
Abstract:
Cancer, a leading cause of global mortality, remains a significant challenge to increasing life expectancy worldwide. Forkhead Box R2 (FOXR2), identified as an oncogene within the FOX gene family, plays a crucial role in developing various endoderm-derived organs. Recent studies have elucidated FOXR2-related pathways and their involvement in both tumor and non-tumor diseases. Dysregulation of FOXR2 has been linked to numerous malignant tumors, spanning the brain, nervous system, thyroid, osteosarcoma, Hodgkin lymphoma, colorectal, liver, pancreatic, lung, breast, ovarian, prostate, female genital tract, endometrial, and uterine cancers. Despite extensive research on FOXR2 dysregulation, its practical applications remain underexplored. This review delves into the mechanisms underlying FOXR2 dysregulation during oncogenesis and its implications for cancer diagnosis, prognosis, and treatment.
Insights
Forkhead Box R2 (FOXR2) is an oncogene implicated in many cancers. Understanding FOXR2 dysregulation is key for improving cancer diagnosis, prognosis, and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer remains a primary cause of global mortality, posing a significant challenge to increasing life expectancy.
- Forkhead Box R2 (FOXR2), a member of the FOX gene family, is recognized as an oncogene crucial for endoderm-derived organ development.
- FOXR2 dysregulation is associated with a wide spectrum of malignant tumors, including those of the brain, nervous system, thyroid, and various visceral organs.
Purpose of the Study:
- To review the mechanisms of FOXR2 dysregulation in oncogenesis.
- To explore the implications of FOXR2 dysregulation for cancer diagnosis, prognosis, and therapeutic interventions.
Main Methods:
- Literature review of FOXR2-related pathways and their involvement in oncogenesis.
- Analysis of studies linking FOXR2 dysregulation to diverse cancer types.
- Synthesis of current knowledge on FOXR2's role in tumor development and progression.
Main Results:
- FOXR2 dysregulation is a common feature across numerous cancers, affecting multiple organ systems.
- FOXR2-related pathways are involved in both tumor initiation and progression.
- Despite its established role, the clinical utility of FOXR2 in cancer management is largely underexplored.
Conclusions:
- FOXR2 is a significant oncogene with broad implications in human carcinogenesis.
- Further research into FOXR2 dysregulation mechanisms could unlock novel diagnostic and therapeutic strategies for various cancers.
- Targeting FOXR2 pathways may offer potential for improved cancer treatment outcomes.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Mitogens and the Cell Cycle
Non-Canonical Wnt Signaling Pathways